Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Nymox Pharmaceutical Corp | NYMX | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.20 | 0.20 |
Noticias Recientes
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
28/3/2024 | 12:03 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
06/11/2023 | 08:59 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
08/9/2023 | 09:13 | EDGAR2 | Form 25-NSE - Notification filed by national security.. |
25/7/2023 | 15:04 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
25/7/2023 | 09:33 | GLOBE | Nymox Reports Successful New NYMOZARFEX (TM) Long-Term.. |
18/7/2023 | 09:45 | GLOBE | Nymox Reports on U.S. Patent Issuances |
13/7/2023 | 09:16 | GLOBE | Nymox Update |
12/7/2023 | 08:30 | GLOBE | Nymox Announces Appointment Of Patrick Doody as Vice.. |
07/7/2023 | 16:02 | GLOBE | NYMOX Update |
05/7/2023 | 17:11 | GLOBE | Nymox Delisting from NASDAQ |
29/6/2023 | 16:15 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
10/5/2023 | 09:00 | GLOBE | Nymox Provides Current Update |